NAIROBI, Kenya, April 21 – Pharmaceutical Society of Kenya (PSK) wants action taken against any pharmaceutical outlet found illegally selling medications to minors.
PSK President Louis Machogu has noted concerns raised by unspecified media outlets regarding the reported sale of Rohypnol, an anti-anxiety medication, to minors in Mombasa.
Machogu emphasized that such practices are unethical and violate pharmaceutical standards and ethical conduct.
“We are deeply concerned by the recent reports circulating in the media regarding the alleged sale of Rohypnol, an anti-anxiety medication, to minors in Mombasa. These reports have highlighted a serious issue that demands immediate attention and actions from all stakeholders involved,” he stated.
PSK reiterated its commitment to collaborating closely with the Pharmacy and Poisons Board (PPB) to promptly address any complaints or issues regarding the conduct and professional ethics of pharmacists.
Contrary to circulating reports portraying the pharmaceutical profession as incompetent, PSK denied such claims.
Machogu emphasized the agency adherence to stringent ethical guidelines, particularly prohibiting the sale of prescription medication to unaccompanied minors.
PSK further encouraged the public to verify the registration status of both pharmacies and pharmacists using the PPB portal.
This step, according to PSK, ensures accountability and strengthens trust between pharmacists and the public.
“Contrary to the sensationalized reports, Pharmacists in Kenya are bound by strict regulations and ethical guidelines that prohibit the sale of prescription medications without verification of prescription furthermore to unaccompanied minors,” Machogu said.
